Gemini Therapeutics GMTX

$ 1.56 0.97%

Quarterly report 2024-Q3
added 11-12-2024

Gemini Therapeutics EV/EBITDA Ratio 2011-2024 | GMTX

Annual EV/EBITDA Ratio Gemini Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.17	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.17	1.17	1.17